| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0005 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.23 | 0.0005 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0008 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.22 | 0.001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |